Allarity Therapeutics Inc 뉴스 - ALLR | 주식 나스닥

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Patient enrollment set to begin at leading U.S. clinical trial sites, new drug product already deliveredTrial...

Form 8-K - Current report

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Boston (February 6, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2...

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Boston (January 30, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2...

Form 8-K - Current report

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights

Cash balance at $18.5 millionStrengthened leadership team with new members driving stenoparib...

Monksdream 10 시간 전

ALLR, new 52 week low

👍️0

MC10459 12 시간 전

This was at $250 pps a year ago. This thing dropped like a rock. Someone tell me why those days aren't long gone.

👍️0

georgie18 13 시간 전

ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

omda 2 일 전

Hey to all, When the clinical trials are concluded with the stenoparib will this get an FDA approved?

👍️0

georgie18 4 일 전

ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

georgie18 5 일 전

ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

stocktowatch 2 주 전

$ALLR An in-depth review of Allarity’s maturing clinical data, in collaboration with leading clinical investigators, prompted Allarity to design this new Phase 2 protocol to enable a more aggressive push of stenoparib toward regulatory approval. The protocol will enable new enrollment expressly focusing on patients with advanced, recurrent, platinum-resistant disease, a group that has shown durable clinical benefit from stenoparib in the current phase 2 trial and who have only limited treatment options following standard chemotherapy. In addition to expanding and deepening the clinical data set necessary for regulatory approval, this trial is also designed to enhance the understanding of stenoparib’s unique therapeutic mechanism of action. Of particular interest will be the impact of stenoparib treatment on the Wnt pathway, a key cellular pathway repeatedly shown to be involved in advanced ovarian cancers as well as many other advanced cancer types, most notably colon cancers. A richer understanding of stenoparib’s potential for controlling the Wnt pathway—a key aspect of the newly designed trial—could further distinguish stenoparib as a unique investigational cancer treatment.

👍️0

stocktowatch 3 주 전

$ALLR News - Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
https://finance.yahoo.com/news/allarity-therapeutics-announces-expansion-phase-130000934.html

👍️ 1

georgie18 3 주 전

ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

georgie18 3 주 전

ALLR...$1.15...Trying to turn up here...🥳

👍️0

omda 3 주 전

What's happening to this company, will it become bankrupt and permanently delisted. I gave it a thumbs up for cancer research. Was fraud detected in the company financials report or maybe the clinic trials have failed. Any comments on this?

👍️0

georgie18 3 주 전

ALLR...$1.19...Reversing off the $1 LOD...🥳

👍️0

koolmc 3 주 전

1.20s from 1 dip, get it past 1.30's again chance for bigger move imo

👍️0

stocktowatch 3 주 전

$ALLR Allarity Therapeutics (ALLR): A Biotech Turnaround With FDA Fast-Track Potential

1. The Troubled Past: Poor Leadership and Financial Mismanagement
Allarity Therapeutics was once plagued by severe financial mismanagement, regulatory concerns, and questionable leadership. The company faced Wells Notices, an SEC investigation, and disastrous financing decisions, leaving investors uncertain about its future.

Key Issues Under Previous Leadership:
? Wells Notices & SEC Investigation: The company was under regulatory scrutiny for past financial decisions. (Source)

? Dilutive Financing: Multiple rounds of toxic financing and poor capital structure decisions led to massive shareholder dilution. (Source)

? Stock Price Collapse & Nasdaq Compliance Issues: Due to financial mismanagement, the company faced delisting threats from Nasdaq. (Source)

👍️0

luckydude777 3 주 전

If I was a Market Maker, I would do to this stock what has been DONE to it this last week. Attempt to break the confidence of everyone connected with the company so cheaper shares could be accumulated.

CHEAPER SHARES?!!!!!!!!!!!!!!!!!!!

Sure. Market Makers KNOW that companies like ATTR who are devoting their time and talent to helping cure people of cancerous issues are WORTH far more than any AI stock you can buy right now.

Watch disgruntled AI chip investors TURN to a sector that is trying to extend the quality of life for humanity. ALLR fits the bill for me.

👍️0

koolmc 4 주 전

peeps were expecting news yesterday besides the settlement

👍️0

Millenium323 4 주 전

$ALLR only has a market cap of around $6 million with a drug in Phase 2 clinical trials. It should be trading at $20 per share right now. Oh well it looks like I will be adding. No one ever said the stock market was efficient.

👍️0

georgie18 4 주 전

ALLR...$1.23...Bouncing off the $1.12 dip...🥳

👍️0

LonesomeGeorge 4 주 전

Well, this is fantastic.

👍️0

koolmc 4 주 전

grabbed some 1.17's on dip heading into the data release.

ALLR...$1.36...🥳 ... https://www.globenewswire.com/news-release/2025/01/30/3017967/0/en/Allarity-Therapeutics-Announces-Filing-of-Form-8-K-Regarding-Settlement-Agreement-in-Principle-with-SEC.html

👍️0

15for2 4 주 전

looked like a low volume stop-loss sweep, imo
could get really interesting this afternoon
$ALLR

RNAZ flying today with little more than speculation. Has more shares outstanding than ALLR and no assurance it has medicine any better than ALLR's ... far as anyone is sharing right now.

I'm looking for ALLR to start climbing near the close today and maybe higher in A/H.s. Tomorrow morning should get a lot of generous upside going into the mid-afternoon if all goes well.

👍️0

luckydude777 4 주 전

Added to the treasure chest some of those $1.49's.

👍️0

luckydude777 4 주 전

$ALLR presenting tomorrow approx 2:15 pm
Fasten your seatbelts

👍️0

boston127 4 주 전

I need toi follow your alerts.

Good call.

👍️0

Law of Averages 4 주 전

Maybe we might test next resistance level at $2.25

👍️0

georgie18 4 주 전

Ruff Ruff...🥳...Hit $1.99 of my $1 Alert...

👍️0

koolmc 4 주 전

nice little pop riding the rest after taking profits gl

👍️0

georgie18 4 주 전

Their all dogs until their not... Well I bought this dog at $1 and it hit $1.72...🥳...

👍️ 1 💯 1

boston127 4 주 전

ALLR is a dog.

company has great products, still being tested, but has no value. It is worth minus $11M. Looks like a P&D.

ALLR...$1.62...Off my $1 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 672254

Friday, January 24, 2025 9:53:30 AM

Post#
672296
of 672488
ALLR...$1.46...Off my $1 Alert...🥳Looking for Double Top Break here...

georgie18

Member Level
Re: georgie18 post# 388997

Friday, January 24, 2025 7:28:59 AM

Post#
389007
of 389045
ALLR...$133s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 672217

Thursday, January 23, 2025 7:14:06 PM

Post#
672237
of 672252
ALLR...$1.28s hitting here...🥳...Bullish Engulfing Candle on todays close....

georgie18

Member Level
Re: georgie18 post# 388353

Thursday, January 23, 2025 3:52:10 PM

Post#
388987
of 388996
ALLR...$1.25...Hit $1.50...HOD...🥳
georgie18

Member Level
Re: georgie18 post# 671010

Friday, January 10, 2025 1:13:53 PM

Post#
671057
of 672215
ALLR...$1.13s clearing here...🥳

georgie18

Member Level
Re: None

Friday, January 10, 2025 9:35:44 AM

Post#
470
of 470
ALLR...$1...🥳...scaling in here...

👍️0

koolmc 4 주 전

trying for those 1.60's again

👍️0

surf1944 1 월 전

$ALLR Finally some clarity on the true value of ALLR coming this week, the chart is primed, the officers filed a huge number of insider shares, if the results continue to be positive ALLR can go to $10-20 quickly.

http://ddr-inhibitors-summit.com/speaker/thomas-jensen/

https://clinicaltrials.gov/search?term=2x-121&viewType=Table

https://www.nasdaq.com/market-activity/stocks/allr/sec-filings

👍️0

luckydude777 1 월 전

Yep - got a winner here.

👍️0

georgie18 1 월 전

ALLR...$1.46...Off my $1 Alert...🥳Looking for Double Top Break here...

georgie18

Member Level
Re: georgie18 post# 388997

Friday, January 24, 2025 7:28:59 AM

Post#
389007
of 389045
ALLR...$133s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 672217

Thursday, January 23, 2025 7:14:06 PM

Post#
672237
of 672252
ALLR...$1.28s hitting here...🥳...Bullish Engulfing Candle on todays close....

georgie18

Member Level
Re: georgie18 post# 388353

Thursday, January 23, 2025 3:52:10 PM

Post#
388987
of 388996
ALLR...$1.25...Hit $1.50...HOD...🥳
georgie18

Member Level
Re: georgie18 post# 671010

Friday, January 10, 2025 1:13:53 PM

Post#
671057
of 672215
ALLR...$1.13s clearing here...🥳

georgie18

Member Level
Re: None

Friday, January 10, 2025 9:35:44 AM

Post#
470
of 470
ALLR...$1...🥳...scaling in here...

👍️0

georgie18 1 월 전

ALLR...$133s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 672217

Thursday, January 23, 2025 7:14:06 PM

Post#
672237
of 672252
ALLR...$1.28s hitting here...🥳...Bullish Engulfing Candle on todays close....

georgie18

Member Level
Re: georgie18 post# 388353

Thursday, January 23, 2025 3:52:10 PM

Post#
388987
of 388996
ALLR...$1.25...Hit $1.50...HOD...🥳
georgie18

Member Level
Re: georgie18 post# 671010

Friday, January 10, 2025 1:13:53 PM

Post#
671057
of 672215
ALLR...$1.13s clearing here...🥳

georgie18

Member Level
Re: None

Friday, January 10, 2025 9:35:44 AM

Post#
470
of 470
ALLR...$1...🥳...scaling in here...

MartinLutherKing 1 월 전

ALLR Live the dream brothers RNAZ Cure to cancer

👍️0

georgie18 1 월 전

ALLR...$1.28s hitting here...🥳...Bullish Engulfing Candle on todays close....

georgie18

Member Level
Re: georgie18 post# 388353

Thursday, January 23, 2025 3:52:10 PM

Post#
388987
of 388996
ALLR...$1.25...Hit $1.50...HOD...🥳
georgie18

Member Level
Re: georgie18 post# 671010

Friday, January 10, 2025 1:13:53 PM

Post#
671057
of 672215
ALLR...$1.13s clearing here...🥳

georgie18

Member Level
Re: None

Friday, January 10, 2025 9:35:44 AM

Post#
470
of 470
ALLR...$1...🥳...scaling in here...

👍️0

georgie18 1 월 전

ALLR...$1.25...Hit $1.50...HOD...🥳Off my $1 Alert...

georgie18

Member Level
Re: georgie18 post# 671010

Friday, January 10, 2025 1:13:53 PM

Post#
671057
of 672215
ALLR...$1.13s clearing here...🥳

georgie18

Member Level
Re: None

Friday, January 10, 2025 9:35:44 AM

Post#
470
of 470
ALLR...$1...🥳...scaling in here...

ALLR...$1.13s clearing here...🥳

georgie18

Member Level
Re: None

Friday, January 10, 2025 9:35:44 AM

Post#
470
of 470
ALLR...$1...🥳...scaling in here...

👍️0

georgie18 1 월 전

ALLR...$1...🥳...scaling in here...

👍️0

Law of Averages 2 월 전

Yes but this had a long Inverted Hammer candle at the close this should continue to move upwards. Also ALLR is making higher lows and higher highs. 📈

Law of Averages 2 월 전

Big volume breakout on ALLR.

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Allarity Therapeutics Inc (ALLR)

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

ALLR 뉴스

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Form 8-K - Current report

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Form 8-K - Current report

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights

ALLR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Allarity Therapeutics Inc (ALLR) 뉴스

Allarity Therapeutics Inc (ALLR)

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

ALLR 뉴스

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Form 8-K - Current report

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Form 8-K - Current report

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights

ALLR Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거